|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
WHO00664175X |
| 003 |
DE-627 |
| 005 |
20230425165656.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210507s2023 xx |||||o 00| ||dut c |
| 035 |
|
|
|a (DE-627)WHO00664175X
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)NTR6332
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)NL5966
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)NL59838.042.16
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a dut
|
| 245 |
1 |
0 |
|a Mannelijke vruchtbaarheid na een hoge dosis radioactief jodium voor de behandeling van gedifferentieerd schildklierkanker
|b Male fertility after treatment with a high dose radioiodine for differentiated thyroid carcinoma
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2017-05-09, Last updated: 2023-04-06
|
| 650 |
|
4 |
|a Medical Condition: Differentiated thyroid cancer (DTC/Gedifferentieerd schildkliercarcinoomMale fertility/Mannelijke fertiliteitRadioactive iodine/Radioactie jodium
|
| 650 |
|
4 |
|a Study Type: Observational non invasive
|
| 650 |
|
4 |
|a Recruitment Status: Recruiting
|
| 650 |
|
4 |
|a 610
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2023) vom: 03. Apr.
|
| 773 |
1 |
8 |
|g year:2023
|g day:03
|g month:04
|
| 856 |
4 |
0 |
|u https://www.onderzoekmetmensen.nl/en/trial/23189
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2023
|b 03
|c 04
|
Klinische Studie